Jubilant Ingrevia Ltd (JUBLINGREA) is currently trading at 666.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Jubilant Ingrevia is a global player in Specialty Chemicals, CDMO, Nutrition & Health Solutions serving diverse industries. Its diversified product portfolio includes pyridine derivatives, fine chemicals, pharma, and agro intermediates. The company is prioritizing expansion, evidenced by new plant constructions aimed at boosting production in agrochemical and specialty chemicals sectors. This will support increased demand and strategic growth expectations. FTAs signed with major regions are anticipated to increase its competitive footing in the US and EU markets, aligning its strategic ambitions with global trade dynamics. Despite global pricing pressures, the company maintains strong operational resilience, leveraging volume growth and strategic cost optimization to sustain stable performance. Jubilant Ingrevia is also focusing on emerging segments like semiconductors and AI-applications, positioning itself strategically in high-growth innovation spaces.

Over the past 52 weeks, Jubilant Ingrevia Ltd has traded between a low of ₹535.30 and a high of ₹794.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Jubilant Ingrevia Ltd has a market capitalization of approximately 10,711.66. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Jubilant Ingrevia Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 34.71 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 10,711.66 Cr, Jubilant Ingrevia Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Jubilant Ingrevia Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Jubilant Ingrevia Ltd is 34.71. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Shareholders approved a final dividend of ₹2.50 per equity share for FY26 at the AGM held on August 26, 2026.

Jubilant Ingrevia has entered into a binding agreement to acquire a 40% strategic equity stake in Zettaone Technologies India.

Consolidated revenue from operations was Rs 1,300.3 crore in Q1 FY27, up about 25% year-on-year and about 10% quarter-on-quarter.

Uniresearch estimates Q1 FY27 revenue at ₹1,052 crore, compared with ₹1,038 crore in Q1 FY26, implying 1.4% year-on-year growth.